8YSH

MERS-CoV RBD in complex with nanobody Nb14

8YSH の概要

• エントリーDOI: 10.2210/pdb8ysh/pdb
• 分子名称: Spike glycoprotein, Nb14, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (5 entities in total)
• 機能のキーワード: mers-cov nanobody nb14, viral protein
• 由来する生物種: Middle East respiratory syndrome-related coronavirus (MERS-CoV); 詳細
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 36345.68

構造登録者

Wang, Y.X.,Ma, S. (登録日: 2024-03-23, 公開日: 2024-09-11, 最終更新日: 2024-11-20)

主引用文献

Ma, S.,Zhang, D.,Wang, Q.,Zhu, L.,Wu, X.,Ye, S.,Wang, Y.
Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain.
Plos Pathog., 20:e1012438-e1012438, 2024

PubMed Abstract: The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) causes severe and fatal acute respiratory disease in humans. High fatality rates and continued infectiousness remain a pressing concern for global health preparedness. Antibodies targeted at the receptor-binding domain (RBD) are major countermeasures against human viral infection. Here, we report four potent nanobodies against MERS-CoV, which are isolated from alpaca, and especially the potency of Nb14 is highest in the pseudotyped virus assay. Structural studies show that Nb14 framework regions (FRs) are mainly involved in interactions targeting a novel epitope, which is entirely distinct from all previously reported antibodies, and disrupt the protein-carbohydrate interaction between residue W535 of RBD and hDPP4 N229-linked carbohydrate moiety (hDPP4-N229-glycan). Different from Nb14, Nb9 targets the cryptic face of RBD, which is distinctive from the hDPP4 binding site and the Nb14 epitope, and it induces the β5-β6 loop to inflect towards a shallow groove of the RBD and dampens the accommodation of a short helix of hDPP4. The particularly striking epitopes endow the two Nbs administrate synergistically in the pseudotyped MERS-CoV assays. These results not only character unprecedented epitopes for antibody recognition but also provide promising agents for prophylaxis and therapy of MERS-CoV infection.

PubMed: 39141662
DOI: 10.1371/journal.ppat.1012438

実験手法

X-RAY DIFFRACTION (1.99 Å)